Table 3 Summary of ILCEM described in prior case reports and series.

From: Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity

 

Clinicopathologic features

          

Case reports and series

Number of cases

Age (yrs)

Tumor sizea (cm)

Tumor grade

Nuclear grade

Signet ring cells (number of cases)

Evidence of positive lymph node(s)

ER-positive

PR-positive

HER2-positive

Follow-up data available

Follow-up duration (months)

Recurrence (local or distant)

Death due to breast cancer

Rosa et al.12

1

60

9

NA

2

1

Yesb

Yes

Yes

No

No

NA

NA

NA

Yu et al.19

1

65

3

NA

NA

1

Yes

Yes

No

Yes

No

NA

NA

NA

Haltas et al.17

1

43

2.5

NA

NA

1

Yes

Yes

Yes

No

No

NA

NA

NA

Bari et al.14

1

38

3.5

NA

NA

1

Yes

Yes

Yes

No

No

NA

NA

NA

Gomez Macias et al.16

1

60

0.9

1

1

1

No

Yes

Yes

No

No

NA

NA

NA

Cserni et al.22

8

Median: 63 (range: 45-75)

2.2–9

3 (n = 1); 2 (n = 7)

3 (n = 1); 2 (n = 7)

8

Yes in 5/8 cases

Yes

Yes in 7/8 cases

Yes in 1/8 cases

Yes in 7/8 cases

Median: 26 (range: 2 to 68)

3/7 cases

2/7 cases

Boukhechba et al.15

1

75

1.9

NA

NA

1

NA

Yes

No

No

No

NA

NA

NA

Singh et al.23

4

Median: 77 (range: 70–87)

0.8–10

3 (n = 2); 2 (n = 1); 1 (n = 1)

NA

3/4 cases

Yes in 1/3 cases

Yes

NA

No

No

NA

NA

NA

Koufopoulos et al.18

1

65

1.3

2

NA

1

No

Yes

No

No

Yes

10

No

No

Baig et al.20

1

67

6

3

3

1

Noc

Yes

No

No

No

NA

NA

NA

Burky et al.21

1

70

2.3

3

3

1

No

Yes

Yes

Yes

Yes

8

No

No

Soong (this study)

17

Median 66 (range 31-77)

0.7-7.3

3 (n = 4); 2 (n = 13)

3 (n = 11); 2 (n = 6)

10 (59%)

Yes in 7/12 casesd

Yes

Yes in 12/17 cases

Yes in 2/17 cases

Yes in 12/17 cases

Median: 83.5 (range 3 to 171)

8/12 cases

4/12 cases

Totals

38

Median 62 (range 31–87)

Range 0.7–10

3 (n = 9); 2 (n = 22); 1 (n = 2)

3 (n = 14); 2 (n = 15); 1 (n = 1)

30/38 (79%)

Yes in 17/31 (55%)

Yes in 38/38 (100%)

Yes in 27/37 (73%)

Yes in 4 of 38 (11%)

Yes in 21

Median 29 (range 2 to 171)

11/21 (52%)

6/21 (29%)

  1. aLargest tumor size is listed if tumor was reported as multifocal.
  2. bBased on reported clinical imaging data. No lymph nodes were sampled for pathologic evaluation. The patient also had bone metastases and a smaller contralateral invasive ductal carcinoma.
  3. cIsolated tumor cells in lymph node in this case.
  4. dOne patient had isolated tumor cells in a node which was classified as a negative lymph node.
  5. NA–Information is not available in reported cases.